自动化溶液配制输送系统在水痘疫苗生产中的应用
Application of Automatic System for the Preparation and Delivery of Sterile Solutions in Varicella Vaccine Production

作者: 郑 波 :上海大学生命科学学院,上海;上海生物制品研究所有限责任公司,上海; 梁 辰 , 马中良 :上海大学生命科学学院,上海; 马中锋 :滨海福马生物医药公司,江苏 盐城;

关键词: 自动化溶液配制输送系统水痘疫苗在位清洗在位灭菌Automatic System for the Preparation and Delivery of Solutions Varicella Vaccine Clean in Place Sterilization in Place

摘要:
目的:应用自动化系统配制输送用于生产水痘疫苗的无菌溶液,以满足水痘疫苗细胞工厂的规模化量产需求,减少批间差异。方法:将采用自动化系统配制输送用于水痘疫苗的传代制备所需溶液,与人工操作方式进行对照,比较两种操作方式的细胞生长情况、操作时间等,并对制备的疫苗原液进行相关检定。结果:在同样细胞复苏量的情况下,采用自动化操作系统比人工操作生产的水痘疫苗批间差异小,操作时间短,且相关检测指标均合格。结论:利用自动化溶液配制输送系统制备用于生产水痘疫苗的无菌溶液,提高了批间均一性,降低人工劳动强度,缩短操作时间,减少转运等中间环节,降低污染风险,可满足水痘疫苗细胞工厂的大规模生产。

Abstract: Objective: Application of automatic system for the preparation and delivery of sterile solutions in varicella vaccine production meets the demand of scale production of varicella vaccine by use of cell factory. And it reduces differences between batches. Methods: The solutions for varicella vaccine passage are prepared by automatic system or manual operation mode. It is compared in cell growth, operating time, and product test of the two modes. Results: In the case of the same amount of cell recovery, almost no differences between the varicella vaccine production batches can be found, and it takes shorter operation time in use of automatic operation system than the manual operation mode. And the detection of indicators is qualified. Conclusion: The use of automatic system to prepare and deliver sterile solutions in varicella vaccine production can improve the homogeneity between vaccine batches, reduce labor intensity, shorten operation time, reduce transportation and other intermediate links, and decline the risk of contamination, which is able to meet the requirements for varicella vaccine cell factory scale production.

文章引用: 郑 波 , 梁 辰 , 马中锋 , 马中良 (2015) 自动化溶液配制输送系统在水痘疫苗生产中的应用。 化学工程与技术, 5, 136-141. doi: 10.12677/HJCET.2015.56020

参考文献

[1] 许青, 徐爱强. 我国水痘流行病学分析与水痘疫苗免疫预防研究进展[J]. 中国新药杂志, 2012, 21(10): 1093- 1097.

[2] Kattan, J.A., Sosa, L.E., Bohnwagner, H.D., et al. (2011) Impact of 2-Dose Vaccination on Varicella Epi-demiology: Connecticut-2005-2008. Journal of Infectious Diseases, 203, 509-512.
http://dx.doi.org/10.1093/infdis/jiq081

[3] 唐万琴, 张翔, 朱中奎, 等. 国产与进口水痘减毒活疫苗安全性和免疫效果Meta分析[J]. 中国学校卫生, 2014, 35(2): 237-242.

[4] Vazquez, F.L., Torres, A., Blanco, V., et a1. (2012) Comparison of Relaxation Training with a Cognitive-Behavioral Intervention for Indicated Prevention of De-pression in University Students: A Randomized Controlled Trial. Journal of Psychiatric Research, 46, 1456-1463.
http://dx.doi.org/10.1016/j.jpsychires.2012.08.007

[5] WHO (2014) WHO Model List of Essential Medi-cines.

[6] Carrillo-Santisteve, P. and Lopalco, P.L. (2014) Varicella Vaccination: A Laboured Take-Off. Clinical Microbiology and Infection, 20, 86-91.
http://dx.doi.org/10.1111/1469-0691.12580

[7] 陈志慧, 王宪明, 殷月娣, 等. 水痘减毒活疫苗的研制及免疫效果观察[J]. 国际生物制品学杂志, 2006, 29(3): 97- 100.

[8] 王斐, 单雪峰, 戴长河, 等. 水痘减毒活疫苗生产工艺研究[J]. 中国新药杂志, 2012, 21(10): 1175-1177.

[9] 徐建军, 王宪明, 殷月娣, 等. 冻干水痘减毒活疫苗的生产工艺[J]. 中国生物制品学杂志, 2002, 15(5): 297-298.

[10] Hambleton, S. and Gershon, A.A. (2005) Preventing Varicella-Zoster Disease. Clinical Microbiology Reviews, 18, 70- 80.
http://dx.doi.org/10.1128/CMR.18.1.70-80.2005

[11] 王亮, 杨月莲, 周锋, 等. 细胞工厂在水痘疫苗生产中的应用[J]. 中国新药杂志, 2012, 21(10): 1178-1181.

[12] 周妍, 仲宇航, 王云霞, 等. 细胞工厂制备冻干甲型肝炎减毒活疫苗猴体安全性和免疫原性研究[J]. 预防医学论坛, 2012, 18(7): 526-527.

[13] 周妍, 王云霞, 仲宇航, 等. 细胞工厂制备冻干甲型肝炎减毒活疫苗的研究[J]. 预防医学论坛, 2012, 18(8): 595- 597.

[14] 李红芳, 赵祖波, 任红卫. 应用细胞工厂建立人用狂犬病疫苗连续培养多次收获工艺[J]. 微生物学免疫学进展, 2013, 41(6): 25-29.

[15] 安红, 张海红, 王名强. 细胞工厂培养轮状病毒基因重配株Ls(G3型)条件的优化研究[J]. 微生物学免疫学进展, 20l4, 41(1): 25-30.

[16] WHO (1994) TRS Requirement for Varicella Vaccine (Live).

[17] 陈月菊. 谈大容量注射剂配料系统质量风险及控制方法[J]. 企业科技与发展, 2011, 16(8): 46-47.

[18] 国家药典委员会. 中华人民共和国药典[M]. 北京: 中国医药科技出版社, 2010.

[19] 国家食品药品监督管理局药品认证管理中心. 药品GMP指南(无菌药品) [M]. 北京: 中国医药科技出版社, 2011.

[20] 国家卫生部. 药品生产质量管理规范(2010年修订) [S]. 北京: 人民卫生出版社, 2011.

分享
Top